These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14769395)

  • 21. Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats.
    Blanco-Centurion CA; Shiromani A; Winston E; Shiromani PJ
    Eur J Neurosci; 2006 Oct; 24(7):2084-8. PubMed ID: 17067305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone.
    Blanco-Centurion C; Gerashchenko D; Salin-Pascual RJ; Shiromani PJ
    Eur J Neurosci; 2004 May; 19(10):2741-52. PubMed ID: 15147308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypocretins, peptides associated with narcolepsy].
    Murillo-Rodríguez E; Arias-Carrión O
    Gac Med Mex; 2007; 143(5):421-5. PubMed ID: 18246936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.
    Bourgin P; Huitrón-Résendiz S; Spier AD; Fabre V; Morte B; Criado JR; Sutcliffe JG; Henriksen SJ; de Lecea L
    J Neurosci; 2000 Oct; 20(20):7760-5. PubMed ID: 11027239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression.
    Allard JS; Tizabi Y; Shaffery JP; Manaye K
    Neuropeptides; 2007 Oct; 41(5):329-37. PubMed ID: 17590434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism.
    Peever JH; Lai YY; Siegel JM
    J Neurophysiol; 2003 May; 89(5):2591-600. PubMed ID: 12611960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation.
    Pedrazzoli M; D'Almeida V; Martins PJ; Machado RB; Ling L; Nishino S; Tufik S; Mignot E
    Brain Res; 2004 Jan; 995(1):1-6. PubMed ID: 14644464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala.
    Bisetti A; Cvetkovic V; Serafin M; Bayer L; Machard D; Jones BE; Mühlethaler M
    Neuroscience; 2006 Nov; 142(4):999-1004. PubMed ID: 16996221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
    Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
    Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 33. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
    Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
    Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of hypocretin neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Low PA; Parisi JE
    Acta Neuropathol; 2007 Jan; 113(1):75-80. PubMed ID: 17089135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Narcolepsy--new implications of molecular biology].
    Knudsen S; Jennum PJ
    Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1.
    Deboer T; Overeem S; Visser NA; Duindam H; Frölich M; Lammers GJ; Meijer JH
    Neuroscience; 2004; 129(3):727-32. PubMed ID: 15541893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immobilization induced fos expression in the medial and lateral hypothalamic areas: a limited response of hypocretin neurons.
    Kiss A
    Ideggyogy Sz; 2007 Mar; 60(3-4):192-5. PubMed ID: 17451067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
    Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
    Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
    Kohlmeier KA; Inoue T; Leonard CS
    J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.